Government sources

See also: Regulation overview

Adverse events of 5-alpha-reductase inhibitors. Genetic and Rare Diseases Information Center (GARD), U.S. National Institutes of Health. Unavailable on public web as of 2023. Archived versions: June 20, 2021 and November 21, 2015 (both via Wayback Machine, Internet Archive).

Finasteride: reminder of the risk psychiatric side effects and of sexual side effects (which may persist after discontinuation of treatment). UK Medicines and Healthcare products Regulatory Agency. April 29, 2024.

Men on finasteride asked to stay vigilant for possible psychiatric and sexual side effects. News release. UK Medicines and Healthcare products Regulatory Agency. April 29, 2024.

Post-finasteride syndrome. Prescriber Update (New Zealand Medsafe). 2016 March;37(1):8-9. (Archived at archive.is)